cyclohexanol has been researched along with Atherosclerotic Parkinsonism in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez Iniesta, I; García-Parajuá, P; Magariños, M | 1 |
| Blahak, C; Capelle, HH; Grips, E; Krauss, JK; Weigel, R; Wöhrle, JC | 1 |
| Archambaud, F; Buhl, C; Chouinard, G; Corruble, E; Hardy, P; Prigent, A; Schuster, JP | 1 |
3 other study(ies) available for cyclohexanol and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
[Reversible and dose-related parkinsonism induced by venlafaxine].
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Humans; Male; Parkinson Disease, Secondary; Venlafaxine Hydrochloride | 2003 |
Risperidone-responsive segmental dystonia and pallidal deep brain stimulation.
Topics: Aged; Antidepressive Agents; Combined Modality Therapy; Cyclohexanols; Depression; Dopamine Antagonists; Dystonic Disorders; Electric Stimulation Therapy; Globus Pallidus; Humans; Male; Parkinson Disease, Secondary; Risperidone; Severity of Illness Index; Venlafaxine Hydrochloride | 2003 |
Using striatal dopamine transporter single photon emission computed tomography imaging to rule out Dementia with Lewy Bodies in elderly patients with antipsychotic-induced parkinsonism.
Topics: Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Differential; Dopamine Plasma Membrane Transport Proteins; Female; Haloperidol; Humans; Lewy Body Disease; Neostriatum; Parkinson Disease, Secondary; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tropanes; Venlafaxine Hydrochloride | 2007 |